Male breast cancer is uncommon, but it is a serious and potentially life-threatening disease that requires timely diagnosis and specialized treatment. Because breast cancer is often perceived as a “female disease,” many men ignore early symptoms, leading to delayed presentation and more advanced stages at diagnosis. Awareness, early evaluation, and expert-guided therapy can significantly improve survival and quality of life.
Dr. Lovedeep Singh Chauhan , Consultant Surgical Oncologist in punjab at Max Super Speciality Hospital, provides comprehensive, evidence-based treatment for male breast cancer. With advanced training from Tata Memorial Hospital and extensive experience in surgical oncology, he offers individualized treatment planning supported by a multidisciplinary cancer care approach.
Although men have significantly less breast tissue than women, they do possess ducts and rudimentary glandular structures. Cancer can develop in these tissues when genetic mutations cause uncontrolled cell growth.
Male breast cancer accounts for less than 1% of all breast cancer cases worldwide. However, its rarity does not reduce its seriousness. Because routine screening is not performed in men, diagnosis often happens after a lump becomes noticeable.
The majority of male breast cancers are:
Unlike in women, lobular carcinoma is extremely rare in men due to minimal lobular development.
Several factors contribute to delayed diagnosis:
Because male breast tissue is limited, tumors may quickly invade underlying muscle or skin if not addressed early. Therefore, any suspicious change should be evaluated promptly.
Understanding risk factors helps identify individuals who may benefit from early evaluation.
Most cases occur in men between 60 and 70 years of age.
BRCA2 gene mutation significantly increases risk. Men with a strong family history of breast or ovarian cancer should consider genetic counseling.
Having a first-degree relative with breast cancer raises the likelihood of developing the disease.
Conditions that increase estrogen levels, such as:
Previous chest radiation therapy increases long-term risk.
Undescended testes, orchitis, or prior testicular surgery may alter hormone balance.
Men with one or more of these risk factors should not ignore breast-related symptoms.
Early symptoms are often subtle. The most common presentation is a painless lump beneath the nipple.
Other warning signs include:
Unlike gynecomastia, which is usually soft and symmetrical, cancerous lumps tend to be firm, irregular, and fixed to surrounding tissue. Any new lump in a man should always be evaluated by a surgical oncologist.
Accurate diagnosis forms the foundation of effective treatment.
A detailed history and physical examination are performed to assess lump characteristics and lymph node involvement.
A core needle biopsy is essential to confirm malignancy. This allows:
If invasive cancer is confirmed, staging may include:
Staging follows the TNM system:
Accurate staging determines treatment strategy and prognosis.
Management depends on tumor size, stage, biology, and patient fitness. Treatment is often multimodal.
Surgery remains the primary treatment in most cases. Because of limited breast tissue in men, breast-conserving surgery is rarely feasible. The most common procedure performed is:
This involves removal of:
In early-stage disease without clinically positive nodes, Sentinel Lymph Node Biopsy may be performed to avoid unnecessary full node dissection. Surgery aims for complete tumor removal with clear margins while minimizing complications.
Chemotherapy is recommended in:
It may be administered before surgery (neoadjuvant) to shrink tumors or after surgery (adjuvant) to reduce recurrence risk.
Most male breast cancers are estrogen receptor-positive. Tamoxifen is commonly prescribed for 5–10 years. It significantly reduces recurrence and improves survival. Side effects are discussed in detail during consultation and monitored during follow-up.
If HER2-positive, targeted therapy (e.g., trastuzumab-based regimens) may be recommended.
Radiation is advised in:
It reduces local recurrence risk and improves long-term outcomes.
When detected early, male breast cancer has survival rates comparable to female breast cancer. Prognosis depends on:
Delayed diagnosis remains the primary factor leading to poorer outcomes. Early consultation significantly improves survival.
After treatment, regular follow-up is essential. Follow-up includes:
Lifestyle modifications such as weight management, physical activity, and avoidance of alcohol excess are encouraged. Psychological support is equally important, as men may face emotional distress due to the stigma associated with breast cancer.
Dr. Lovedeep Singh Chauhan is a highly experienced surgical oncologist trained at premier institutions, including Tata Memorial Hospital. He specializes in advanced oncologic surgery with a patient-centered approach.
Multidisciplinary tumor board discussions
Evidence-based treatment protocols
Modern surgical infrastructure
Coordinated medical and radiation oncology services
Individualized treatment planning for every patient
At Max Super Speciality Hospital, patients receive comprehensive cancer care tailored to their needs rather than a one-size-fits-all approach.
Choosing the right oncologist directly impacts outcomes.
The first consultation is comprehensive and structured to ensure you understand your diagnosis and treatment options.
Patients are given adequate time to ask questions and fully understand their options before proceeding with treatment.